Vizora日本語

Pharmarise HoldingsPharmarise Holdings Corporation2796東証スタンダードサービス業FY ending May 2026, consolidated, J-GAAP

Pharmarise Holdings FY ending May 2026 results

About 85% of Pharmarise Holdings's sales come from Dispensing pharmacy, with Cosmetic,drug and convenience store and Other making up much of the rest.

Out of every ¥100 of sales, about ¥2 is left as operating profit.

Revenue changed +9.5% from the prior year, operating profit +234.1%.

Revenue and profit pattern

Revenue and profit upProfit grew faster

Revenue +9.5% · profit +234.1%, calculated from disclosed figures.

Operating leverage: 24.77× (profit growth ÷ revenue growth)

What changed from last year

FY ending May 2025 → FY ending May 2026

Revenue
+9.5%¥63.5B → ¥69.5B
Gross profit
+5.5%¥8.96B → ¥9.46B
Operating income
+234.1%¥293M → ¥979M
Net income attributable to owners
Back to profit-¥367M → ¥114M
Operating cash flow
+150.0%¥1.31B → ¥3.28B
Free cash flow
+319.9%¥609M → ¥2.56B

Where the money goes

FY ending May 2025 → FY ending May 2026

Where ¥100 of sales goes

For every ¥100 Pharmarise Holdings sells, how much goes where, and how much is kept.

FY ending May 2026
Cost of sales
¥86
SG&A
¥12
Operating profit
¥2
Net profit kept
¥0

Annual margin trends

Gross margin13.6%
FY ending May 2021: 15.4%15.4%FY ending May 2022: 15.7%15.7%FY ending May 2023: 15.6%15.6%FY ending May 2024: 15.5%15.5%FY ending May 2025: 14.1%14.1%FY ending May 2026: 13.6%13.6%FY21FY22FY23FY24FY25FY26
Operating margin1.4%
FY ending May 2021: 2.4%2.4%FY ending May 2022: 2.9%2.9%FY ending May 2023: 2.8%2.8%FY ending May 2024: 1.7%1.7%FY ending May 2025: 0.5%0.5%FY ending May 2026: 1.4%1.4%FY21FY22FY23FY24FY25FY26
Net margin0.2%
FY ending May 2021: 0.8%0.8%FY ending May 2022: 0.9%0.9%FY ending May 2023: 0.6%0.6%FY ending May 2024: -0.6%-0.6%FY ending May 2025: -0.6%-0.6%FY ending May 2026: 0.2%0.2%FY21FY22FY23FY24FY25FY26

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending May 2026

Profit by segment

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)

  • EDINET (FSA Japan)

    有価証券報告書－第40期(2025/06/01－2026/05/31)

    ID S100YXWI2026-08-20Open

  • EDINET (FSA Japan)

    有価証券報告書－第39期(2024/06/01－2025/05/31)

    ID S100WL4W2025-08-25Open

  • EDINET (FSA Japan)

    有価証券報告書－第38期(2023/06/01－2024/05/31)

    ID S100UB272024-08-30Open

  • EDINET (FSA Japan)

    有価証券報告書－第37期(2022/06/01－2023/05/31)

    ID S100RSFU2023-08-31Open

  • EDINET (FSA Japan)

    有価証券報告書－第36期(令和3年6月1日－令和4年5月31日)

    ID S100P3F92022-08-26Open

  • EDINET (FSA Japan)

    有価証券報告書－第35期(令和2年6月1日－令和3年5月31日)

    ID S100MCTA2021-08-27Open

Extracted from XBRL: 51 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.

Open MarkdownShare on XSave image